Cargando…
Eligibility for Photoimmunotherapy in Patients with Unresectable Advanced or Recurrent Head and Neck Cancer and Changes before and after Systemic Therapy
SIMPLE SUMMARY: Photoimmunotherapy is a novel cancer treatment that recently became covered by national health insurance only in Japan. We investigated the characteristics of patients with head and neck cancer who can, potentially can, and cannot be treated with photoimmunotherapy (eligible, potenti...
Autores principales: | Shinozaki, Takeshi, Matsuura, Kazuto, Okano, Wataru, Tomioka, Toshifumi, Nishiya, Yukio, Machida, Michiko, Hayashi, Ryuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417553/ https://www.ncbi.nlm.nih.gov/pubmed/37568610 http://dx.doi.org/10.3390/cancers15153795 |
Ejemplares similares
-
Comparison between three age-stratified cohorts reveals poor prognosis of young patients with tongue carcinoma
por: Baba, Daisuke, et al.
Publicado: (2022) -
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma
por: Tahara, Makoto, et al.
Publicado: (2021) -
A Case Series on Pain Accompanying Photoimmunotherapy for Head and Neck Cancer
por: Shibutani, Yuma, et al.
Publicado: (2023) -
Quality-of-Life Evaluation of Patients with Unresectable Locally Advanced or Locally Recurrent Head and Neck Carcinoma Treated with Head and Neck Photoimmunotherapy
por: Okamoto, Isaku, et al.
Publicado: (2022) -
Salvage Reconstructive Surgery During Nivolumab Therapy for a Patient With Hypopharyngeal Cancer
por: Tsushima, Nayuta, et al.
Publicado: (2020)